{"id":606,"date":"2025-08-25T14:16:15","date_gmt":"2025-08-25T14:16:15","guid":{"rendered":"https:\/\/www.rathaus-apotheke-kerpen.de\/werbeaktionen\/?p=606"},"modified":"2025-08-25T14:16:15","modified_gmt":"2025-08-25T14:16:15","slug":"neue-hoffnung-fuer-lungenkrebs-patienten-fda-stuft-izalontamab-brengitecan-als-vielversprechende-therapie-ein","status":"publish","type":"post","link":"https:\/\/www.rathaus-apotheke-kerpen.de\/werbeaktionen\/neue-hoffnung-fuer-lungenkrebs-patienten-fda-stuft-izalontamab-brengitecan-als-vielversprechende-therapie-ein\/","title":{"rendered":"Neue Hoffnung f\u00fcr Lungenkrebs-Patienten: FDA stuft izalontamab brengitecan als vielversprechende Therapie ein"},"content":{"rendered":"<p>Die US-amerikanische Arzneimittelbeh\u00f6rde <a href=\"https:\/\/www.fda.gov\/\" data-internallinksmanager029f6b8e52c=\"8\" title=\"fda\">FDA<\/a> hat dem Medikament izalontamab brengitecan (kurz iza-bren) den Status einer vielversprechenden Therapie (Breakthrough Therapy Designation) zugesprochen. Das Medikament wird von den Unternehmen SystImmune und Bristol Myers Squibb entwickelt und k\u00f6nnte f\u00fcr bestimmte Patienten mit fortgeschrittenem nicht-kleinzelligem Lungenkrebs (NSCLC) eine neue Behandlungsoption bieten. Die Zulassung gilt f\u00fcr Patienten, deren Tumore spezifische Mutationen im EGFR-Gen aufweisen und deren Krebs trotz fr\u00fcherer Therapien mit gezielten EGFR-Medikamenten und Chemotherapie fortgeschritten ist. Iza-bren ist ein Antik\u00f6rper-Wirkstoff-Konjugat, das sowohl die EGFR- als auch die HER3-Proteine blockiert \u2013 beides sind Proteine, die das Tumorwachstum f\u00f6rdern. Gleichzeitig liefert es einen toxischen Wirkstoff, um die Krebszellen gezielt zu zerst\u00f6ren. Die Entscheidung der FDA basiert auf den Ergebnissen dreier laufender Studien in China, den USA, Europa und Japan. Diese zeigen, dass iza-bren m\u00f6glicherweise eine bessere Tumor-Kontrolle erm\u00f6glicht als bestehende Therapien, wobei die Nebenwirkungen als gut beherrschbar gelten. &#8216;Die Anerkennung durch die FDA unterstreicht das Potenzial von iza-bren, die Behandlungsergebnisse f\u00fcr Patienten mit EGFR-Mutation-NSCLC deutlich zu verbessern&#8217;, erkl\u00e4rt Jonathan Cheng, medizinischer Leiter bei SystImmune. Lungenkrebs ist weltweit die h\u00e4ufigste Krebs-Todesursache. Nach dem Versagen von Standardtherapien gibt es bisher nur begrenzte Behandlungsm\u00f6glichkeiten, was die Notwendigkeit neuer Therapieoptionen wie iza-bren verdeutlicht.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Die US-amerikanische Arzneimittelbeh\u00f6rde FDA hat dem Medikament izalontamab brengitecan (kurz iza-bren) den Status einer vielversprechenden Therapie (Breakthrough Therapy Designation) zugesprochen. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":607,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[454],"tags":[],"class_list":["post-606","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmazeutische-nachrichten"],"_links":{"self":[{"href":"https:\/\/www.rathaus-apotheke-kerpen.de\/werbeaktionen\/wp-json\/wp\/v2\/posts\/606","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rathaus-apotheke-kerpen.de\/werbeaktionen\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rathaus-apotheke-kerpen.de\/werbeaktionen\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rathaus-apotheke-kerpen.de\/werbeaktionen\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rathaus-apotheke-kerpen.de\/werbeaktionen\/wp-json\/wp\/v2\/comments?post=606"}],"version-history":[{"count":1,"href":"https:\/\/www.rathaus-apotheke-kerpen.de\/werbeaktionen\/wp-json\/wp\/v2\/posts\/606\/revisions"}],"predecessor-version":[{"id":618,"href":"https:\/\/www.rathaus-apotheke-kerpen.de\/werbeaktionen\/wp-json\/wp\/v2\/posts\/606\/revisions\/618"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rathaus-apotheke-kerpen.de\/werbeaktionen\/wp-json\/wp\/v2\/media\/607"}],"wp:attachment":[{"href":"https:\/\/www.rathaus-apotheke-kerpen.de\/werbeaktionen\/wp-json\/wp\/v2\/media?parent=606"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rathaus-apotheke-kerpen.de\/werbeaktionen\/wp-json\/wp\/v2\/categories?post=606"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rathaus-apotheke-kerpen.de\/werbeaktionen\/wp-json\/wp\/v2\/tags?post=606"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}